https://www.cnbc.com/2023/03/09/alzheimers-eli-lilly-treatment-solanezumab-failed-to-slow-disease.html
0
0
3/9/23 at 4:34am
Organization
CNBC
Author
Spencer Kimball
Solanezumab's failure is a blow to efforts to treat Alzheimer's in people who have not yet shown clinical symptoms.
Create an account
or login to join the discussion